Epigenetic regulation of chemokine ( CC ‐motif) ligand 2 in inflammatory diseases
Cell Proliferation · 2023-07 · 56 (7)
DOI: 10.1111/cpr.13428 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Proliferation, online erschienen am 05.03.2023. Verfasst von Yingyi Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Tissue Regeneration and Immunology and Department of Periodontics, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruc…. Hauptthemen laut MEDLINE: Chemokine CCL2, Epigenesis, Genetic. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support, Beijing Municipal Administration of Hospitals' Ascent Plan, Beijing Municipal Administration of Hospitals' Youth Programme.
Abstract (Originalsprache)
Appropriate responses to inflammation are conducive to pathogen elimination and tissue repair, while uncontrolled inflammatory reactions are likely to result in the damage of tissues. Chemokine (CC‐motif) Ligand 2 (CCL2) is the main chemokine and activator of monocytes, macrophages, and neutrophils. CCL2 played a key role in amplifying and accelerating the inflammatory cascade and is closely related to chronic non‐controllable inflammation (cirrhosis, neuropathic pain, insulin resistance, atherosclerosis, deforming arthritis, ischemic injury, cancer, etc.). The crucial regulatory roles of CCL2 may provide potential targets for the treatment of inflammatory diseases. Therefore, we presented a review of the regulatory mechanisms of CCL2. Gene expression is largely affected by the state of chromatin. Different epigenetic modifications, including DNA methylation, post‐translational modification of histones, histone variants, ATP‐dependent chromatin remodelling, and non‐coding RNA, could affect the ‘open’ or ‘closed’ state of DNA, and then significantly affect the expression of target genes. Since most epigenetic modifications are proven to be reversible, targeting the epigenetic mechanisms of CCL2 is expected to be a promising therapeutic strategy for inflammatory diseases. This review focuses on the epigenetic regulation of CCL2 in inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Tissue Regeneration and Immunology and Department of Periodontics, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Capital Medical University, Beijing, Peop…
- Immunology Research Center for Oral and Systemic Health, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
- Department of Orthodontics, School of Stomatology, Capital Medical University, Beijing, People's Republic of China.
ORCID-Profile: Yingyi Chen, Lili Wu, Yi Liu
Förderung
- Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support
- Beijing Municipal Administration of Hospitals' Ascent Plan
- Beijing Municipal Administration of Hospitals' Youth Programme
- Beijing Stomatological Hospital, Capital Medical University Young Scientist Program
- Innovation Research Team Project of Beijing Stomatology Hospital
- National Key Research and Development Program
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Chen, Y., Liu, S., Wu, L., Liu, Y., Du, J., Luo, Z., Xu, J., Guo, L., & Liu, Y. (2023). Epigenetic regulation of chemokine ( CC ‐motif) ligand 2 in inflammatory diseases. Cell Proliferation, 56(7). https://doi.org/10.1111/cpr.13428
Vancouver
Chen Y, Liu S, Wu L, Liu Y, Du J, Luo Z, et al. Epigenetic regulation of chemokine ( CC ‐motif) ligand 2 in inflammatory diseases. Cell Proliferation. 2023;56(7). doi:10.1111/cpr.13428
BibTeX
@article{Chen2023,
author = {Chen, Yingyi and Liu, Siyan and Wu, Lili and Liu, Yitong and Du, Juan and Luo, Zhenhua and Xu, Junji and Guo, Lijia and Liu, Yi},
title = {Epigenetic regulation of chemokine ( CC ‐motif) ligand 2 in inflammatory diseases},
journal = {Cell Proliferation},
year = {2023},
volume = {56},
number = {7},
doi = {10.1111/cpr.13428}
}
EUVIMED